These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28375079)

  • 21. When is a GM plant not a GM plant?
    Pennisi E
    Science; 2016 Sep; 353(6305):1222. PubMed ID: 27634520
    [No Abstract]   [Full Text] [Related]  

  • 22. [Genome editing in human embryos: ethical concerns and practical applications].
    Akutsu H
    Rinsho Ketsueki; 2019; 60(9):1033-1045. PubMed ID: 31597825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome Editing in Agriculture: Technical and Practical Considerations.
    Jansing J; Schiermeyer A; Schillberg S; Fischer R; Bortesi L
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editing EU legislation to fit plant genome editing: The use of genome editing technologies in plant breeding requires a novel regulatory approach for new plant varieties that involves farmers.
    Ricroch AE; Ammann K; Kuntz M
    EMBO Rep; 2016 Oct; 17(10):1365-1369. PubMed ID: 27629042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene Editing in Humans: Towards a Global and Inclusive Debate for Responsible Research.
    de Lecuona I; Casado M; Marfany G; Lopez Baroni M; Escarrabill M
    Yale J Biol Med; 2017 Dec; 90(4):673-681. PubMed ID: 29259532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges.
    Hurlbut JB; Jasanoff S; Saha K; Ahmed A; Appiah A; Bartholet E; Baylis F; Bennett G; Church G; Cohen IG; Daley G; Finneran K; Hurlbut W; Jaenisch R; Lwoff L; Kimes JP; Mills P; Moses J; Park BS; Parens E; Salzman R; Saxena A; Simmet H; Simoncelli T; Snead OC; Rajan KS; Truog RD; Williams P; Woopen C
    Trends Biotechnol; 2018 Jul; 36(7):639-641. PubMed ID: 29871776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. China tightens rules on gene editing.
    Normile D
    Science; 2019 Mar; 363(6431):1023. PubMed ID: 30846578
    [No Abstract]   [Full Text] [Related]  

  • 29. [Are the Argonauts lost at sea?].
    Jordan B
    Med Sci (Paris); 2017 Feb; 33(2):193-196. PubMed ID: 28240212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rogues and Regulation of Germline Editing.
    Charo RA
    N Engl J Med; 2019 Mar; 380(10):976-980. PubMed ID: 30650001
    [No Abstract]   [Full Text] [Related]  

  • 31. Wake-up call from Hong Kong.
    Dzau VJ; McNutt M; Bai C
    Science; 2018 Dec; 362(6420):1215. PubMed ID: 30545858
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulating germline editing in assisted reproductive technology: An EU cross-disciplinary perspective.
    Nordberg A; Minssen T; Feeney O; de Miguel Beriain I; Galvagni L; Wartiovaara K
    Bioethics; 2020 Jan; 34(1):16-32. PubMed ID: 31877579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What to Expect When Expecting CRISPR Baby Number Four.
    Scott CT; Selin C
    Am J Bioeth; 2019 Mar; 19(3):7-9. PubMed ID: 30896351
    [No Abstract]   [Full Text] [Related]  

  • 34. Off-target genome editing: A new discipline of gene science and a new class of medicine.
    Wang DC; Wang X
    Cell Biol Toxicol; 2019 Jun; 35(3):179-183. PubMed ID: 31030279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
    Demirci Y; Zhang B; Unver T
    J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "CRISPR babies": What does this mean for science and Canada?
    Knoppers BM; Kleiderman E
    CMAJ; 2019 Jan; 191(4):E91-E92. PubMed ID: 30692104
    [No Abstract]   [Full Text] [Related]  

  • 37. Why Include the Public in Genome Editing Governance Deliberation?
    Blasimme A
    AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward Responsible Human Genome Editing.
    Hynes RO; Coller BS; Porteus M
    JAMA; 2017 May; 317(18):1829-1830. PubMed ID: 28395003
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene-edited plants: What is happening now?
    Jansson S
    Physiol Plant; 2018 Dec; 164(4):370-371. PubMed ID: 30461029
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulations on Genome Editing of Human Embryos in Japan: Our Moral Moratorium.
    Nakazawa E; Yamamoto K; Akabayashi A; Akabayashi A
    Camb Q Healthc Ethics; 2018 Jul; 27(3):360-365. PubMed ID: 29845910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.